Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
DYRK1 Blocking Peptide | Login | DYRK1 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
E-Cadherin Blocking Peptide | Login | E-Cadherin Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
E-Cadherin Blocking Peptide | Login | E-Cadherin Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
E-Cadherin Blocking Peptide | Login | E-Cadherin Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
E-Cadherin Blocking Peptide | Login | E-Cadherin Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
ENT1 Blocking Peptide | Login | ENT1 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
Ephrin Receptor A4 Blocking Peptide | Login | Ephrin Receptor A4 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
Ephrin Receptor A8 Blocking Peptide | Login | Ephrin Receptor A8 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
Ephrin Receptor B4 Blocking Peptide | Login | Ephrin Receptor B4 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
ErbB 2 Blocking Peptide | Login | ErbB 2 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
ErbB 2 Blocking Peptide | Login | ErbB 2 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
FAK1 Blocking Peptide | Login | FAK1 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
FAK2 Blocking Peptide | Login | FAK2 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
GPCR GPR40 Blocking Peptide | Login | GPCR GPR40 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
GPCR GPR43 Blocking Peptide | Login | GPCR GPR43 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
GPCR GPR43 Blocking Peptide | Login | GPCR GPR43 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
GPCR GPR120 Blocking Peptide | Login | GPCR GPR120 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
GPCR GPR120 Blocking Peptide FFAR4-412AP | Login | GPCR GPR120 Blocking Peptide FFAR4-412AP | ||||||||||||||||
|
||||||||||||||||||
FGFR1 Blocking Peptide | Login | FGFR1 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
FGFR2 Blocking Peptide | Login | FGFR2 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
Annexin A1 Positive Control | Login | Annexin A1 Positive Control | ||||||||||||||||
|
||||||||||||||||||
Aquaporin 1 Positive Control | Login | Aquaporin 1 Positive Control | ||||||||||||||||
|
||||||||||||||||||
Bcl-XL Positive Control | Login | Bcl-XL Positive Control | ||||||||||||||||
|
||||||||||||||||||
B-raf Positive Control | Login | B-raf Positive Control | ||||||||||||||||
|
||||||||||||||||||
Bone marrow stromal cell antigen 1 Positive Control | Login | Bone marrow stromal cell antigen 1 Positive Control | ||||||||||||||||
|